Megamet PG 2mg/500mg/15mg Tablet SR
Marketer
Windlas Biotech Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Megamet PG 2mg/500mg/15mg Tablet SR
GlycoBalance SR 2mg/500mg/15mg tablets combine ingredients to effectively manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It promotes efficient insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and frequency for GlycoBalance SR tablets; take them with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be performed prior to commencing therapy. Limit alcohol consumption during treatment as it can heighten the risk of adverse reactions.
Primary Ingredients of Megamet PG 2mg/500mg/15mg Tablet SR
No information provided. Unable to rephrase.
Uses of Megamet PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Megamet PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Megamet PG 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
Common Side effects of Megamet PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Megamet PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Megamet PG 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Megamet PG 2mg/500mg/15mg Tablet SR works:
Megamet PG 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Megamet PG 2mg/500mg/15mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Megamet PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Megamet PG 2mg/500mg/15mg tablet likely poses a risk during lactation. Preliminary research in humans indicates potential transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Megamet PG 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Severe kidney disease contraindicates the use of this medication. Consult a physician. Kidney function should be regularly assessed during treatment with Megamet PG 2mg/500mg/15mg SR tablets.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Megamet PG 2mg/500mg/15mg SR tablets. Dosage modification may be necessary; physician consultation is advised. Megamet PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Megamet PG 2mg/500mg/15mg Tablet SR :
Should you forget to take a Megamet PG 2mg/500mg/15mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Megamet PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently